Jonathan Allan, GENERAL COUNSEL & Corporate Secretary at Stoke Therapeutics, Inc. (STOK), sold 19,392 shares at $12.78 ($248K) on 2024-12-06, disclosed to the SEC on 2024-12-10.
Open-market sale of $248k STOK by GENERAL COUNSEL & Corporate Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.78 | 9,696 | $124K | 50.0% |
| 2 | $12.78 | 9,696 | $124K | 50.0% |
| Total | $12.78 avg | 19,392 | $248K | 100% |
| Filing → |
| STOK | SELL | 2026-06-18 | $44K | — | Filing → |
| STOK | SELL | 2026-03-24 | $626K | — | Filing → |
| STOK | SELL | 2026-03-19 | $569K | — | Filing → |